Статья

International Impact of COVID-19 on the Diagnosis of Heart Disease

A. Einstein, L. Shaw, C. Hirschfeld, M. Williams, T. Villines, N. Better, J. Vitola, R. Cerci, S. Dorbala, P. Raggi, A. Choi, B. Lu, V. Sinitsyn, V. Sergienko, T. Kudo, B. Nørgaard, P. Maurovich-Horvat, R. Campisi, E. Milan, L. Louw, A. Allam, M. Bhatia, E. Malkovskiy, B. Goebel, Y. Cohen, M. Randazzo, J. Narula, T. Pascual, Y. Pynda, M. Dondi, D. Paez, C. INCAPS,
2021

Background: The coronavirus disease 2019 (COVID-19) pandemic has adversely affected diagnosis and treatment of noncommunicable diseases. Its effects on delivery of diagnostic care for cardiovascular disease, which remains the leading cause of death worldwide, have not been quantified. Objectives: The study sought to assess COVID-19's impact on global cardiovascular diagnostic procedural volumes and safety practices. Methods: The International Atomic Energy Agency conducted a worldwide survey assessing alterations in cardiovascular procedure volumes and safety practices resulting from COVID-19. Noninvasive and invasive cardiac testing volumes were obtained from participating sites for March and April 2020 and compared with those from March 2019. Availability of personal protective equipment and pandemic-related testing practice changes were ascertained. Results: Surveys were submitted from 909 inpatient and outpatient centers performing cardiac diagnostic procedures, in 108 countries. Procedure volumes decreased 42% from March 2019 to March 2020, and 64% from March 2019 to April 2020. Transthoracic echocardiography decreased by 59%, transesophageal echocardiography 76%, and stress tests 78%, which varied between stress modalities. Coronary angiography (invasive or computed tomography) decreased 55% (p < 0.001 for each procedure). In multivariable regression, significantly greater reduction in procedures occurred for centers in countries with lower gross domestic product. Location in a low-income and lower–middle-income country was associated with an additional 22% reduction in cardiac procedures and less availability of personal protective equipment and telehealth. Conclusions: COVID-19 was associated with a significant and abrupt reduction in cardiovascular diagnostic testing across the globe, especially affecting the world's economically challenged. Further study of cardiovascular outcomes and COVID-19–related changes in care delivery is warranted. © 2021 The Authors

Цитирование

Похожие публикации

Документы

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • A. Einstein
    Seymour, Paul and Gloria Milstein Division of Cardiology, Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York, NY, United States
  • L. Shaw
    Department of Medicine, Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York, NY, United States
  • C. Hirschfeld
    Department of Radiology, Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York, NY, United States
  • M. Williams
    Weill Cornell Medical College/NewYork-Presbyterian Hospital, New York, NY, United States
  • T. Villines
    BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom
  • N. Better
    University of Virginia, Charlottesville, VA, United States
  • J. Vitola
    Royal Melbourne Hospital, University of Melbourne, Melbourne, Victoria, Australia
  • R. Cerci
    Quanta Diagnostico, Curitiba, Brazil
  • S. Dorbala
    Brigham and Women's Hospital, Boston, MA, United States
  • P. Raggi
    University of Alberta, Edmonton, AB, Canada
  • A. Choi
    The George Washington University School of Medicine, Washington, DC, United States
  • B. Lu
    National Center for Cardiovascular Diseases, Beijing, China
  • V. Sinitsyn
    University Hospital, Lomonosov Moscow State University, Moscow, Russian Federation
  • V. Sergienko
    National Medical Research Center of Cardiology of Healthcare Ministry, Moscow, Russian Federation
  • T. Kudo
    Nagasaki University, Nagasaki, Japan
  • B. Nørgaard
    Aarhus University Hospital, Aarhus, Denmark
  • P. Maurovich-Horvat
    Department of Radiology, Medical Imaging Centre, Semmelweis University, Budapest, Hungary
  • R. Campisi
    Diagnóstico Maipú, Buenos Aires, Argentina
  • E. Milan
    Ospedale Cà Foncello, Treviso, Italy
  • L. Louw
    Donald Gordon Medical Centre, Johannesburg, South Africa
  • A. Allam
    Al Azhar University, Cairo, Egypt
  • M. Bhatia
    Fortis Escorts Heart Institute, New Delhi, India
  • E. Malkovskiy
    Columbia College, Columbia University in the City of New York, New York, NY, United States
  • B. Goebel
    Technion - Israel Institute of Technology, Haifa, Israel
  • Y. Cohen
    Mount Sinai Medical Center, New York, NY, United States
  • M. Randazzo
    Philippines Nuclear Research Institute, Manila, the Philippines, Philippines
  • J. Narula
    International Atomic Energy AgencyVienna, Austria
  • T. Pascual
  • Y. Pynda
  • M. Dondi
  • D. Paez
  • C. INCAPS
Название журнала
  • Journal of the American College of Cardiology
Том
  • 77
Выпуск
  • 2
Страницы
  • 173-185
Ключевые слова
  • cardiovascular system examination; global health; health care survey; heart disease; human; international cooperation; COVID-19; Diagnostic Techniques, Cardiovascular; Global Health; Health Care Surveys; Heart Diseases; Humans; International Agencies
Издатель
  • Elsevier Inc.
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus